nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—Niflumic Acid—Leflunomide—systemic scleroderma	0.904	1	CrCrCtD
Ridogrel—TBXAS1—skeletal joint—systemic scleroderma	0.0322	0.345	CbGeAlD
Ridogrel—TBXA2R—artery—systemic scleroderma	0.0153	0.164	CbGeAlD
Ridogrel—TBXA2R—endothelium—systemic scleroderma	0.013	0.139	CbGeAlD
Ridogrel—TBXA2R—blood vessel—systemic scleroderma	0.012	0.128	CbGeAlD
Ridogrel—TBXAS1—connective tissue—systemic scleroderma	0.00538	0.0576	CbGeAlD
Ridogrel—TBXAS1—smooth muscle tissue—systemic scleroderma	0.00492	0.0527	CbGeAlD
Ridogrel—TBXAS1—tendon—systemic scleroderma	0.0037	0.0396	CbGeAlD
Ridogrel—TBXA2R—lung—systemic scleroderma	0.0037	0.0396	CbGeAlD
Ridogrel—TBXAS1—lung—systemic scleroderma	0.00325	0.0348	CbGeAlD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000326	0.154	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.000248	0.117	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (12/13) signalling events—RHOB—systemic scleroderma	0.000248	0.117	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000112	0.053	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000104	0.0494	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—NOS3—systemic scleroderma	9.74e-05	0.0461	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	9.51e-05	0.045	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—EDN1—systemic scleroderma	6.09e-05	0.0288	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SELP—systemic scleroderma	5.76e-05	0.0273	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.71e-05	0.0271	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	5.45e-05	0.0258	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—RHOB—systemic scleroderma	5.38e-05	0.0255	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CSK—systemic scleroderma	4.9e-05	0.0232	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ITGAM—systemic scleroderma	4.61e-05	0.0218	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.33e-05	0.0205	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	4.03e-05	0.0191	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—RHOB—systemic scleroderma	3.4e-05	0.0161	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RHOB—systemic scleroderma	3.09e-05	0.0146	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—EDN1—systemic scleroderma	3.07e-05	0.0145	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	2.76e-05	0.0131	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HSPG2—systemic scleroderma	2.54e-05	0.012	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SMAD7—systemic scleroderma	2.36e-05	0.0112	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MMP1—systemic scleroderma	2.31e-05	0.0109	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.15e-05	0.0102	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL2—systemic scleroderma	2.1e-05	0.00995	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CTGF—systemic scleroderma	1.93e-05	0.00913	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RHOB—systemic scleroderma	1.82e-05	0.00864	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—EDN1—systemic scleroderma	1.74e-05	0.00822	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HSPG2—systemic scleroderma	1.72e-05	0.00815	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NOS3—systemic scleroderma	1.67e-05	0.00793	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CSK—systemic scleroderma	1.66e-05	0.00787	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EDN1—systemic scleroderma	1.58e-05	0.00747	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—systemic scleroderma	1.11e-05	0.00524	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL2—systemic scleroderma	1.08e-05	0.0051	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EDN1—systemic scleroderma	9.31e-06	0.00441	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NOS3—systemic scleroderma	8.39e-06	0.00397	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL2—systemic scleroderma	6.37e-06	0.00302	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOS3—systemic scleroderma	5.67e-06	0.00269	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—systemic scleroderma	4.55e-06	0.00216	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—systemic scleroderma	3.75e-06	0.00178	CbGpPWpGaD
